In our ILD cohort, patients with a DLCO <40% of predicted exhibited a significant decrease in GRP78 levels (524 ng/ml (226-656) vs. 1126 ng/ml (647–1701), p = 0.01; Figure 3). The gene discussed is HSPA5; the disease is interstitial lung disease.